SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001501134-22-000004
Filing Date
2022-02-24
Accepted
2022-02-24 16:06:03
Documents
15
Period of Report
2022-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvta-20220224.htm   iXBRL 8-K 35038
2 EX-99.1 a991pressreleaseforearning.htm EX-99.1 352589
6 invitaelogoa02.jpg GRAPHIC 36208
7 nvta-20220224_g1.jpg GRAPHIC 36208
  Complete submission text file 0001501134-22-000004.txt   690054

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvta-20220224.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvta-20220224_lab.xml EX-101.LAB 24927
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvta-20220224_pre.xml EX-101.PRE 13137
9 EXTRACTED XBRL INSTANCE DOCUMENT nvta-20220224_htm.xml XML 11005
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 22670885
SIC: 8071 Services-Medical Laboratories